Patient-Reported Quality of Life Is an Independent Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation: A Secondary Analysis from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902

Authors
Category Primary study
JournalBlood
Year 2014
This article has no abstract
Epistemonikos ID: 810d51b008060ae20272194119ea048aba1ee4a0
First added on: Feb 19, 2025